Abstract
Background:Depression is frequently accompanied by comorbid symptoms such as anxiety, insomnia, and cognitive impairment, which complicate treatment and adversely affect clinical outcomes. Acupuncture has shown promise as a complementary therapy; however, the efficacy of acupuncture combined with selective serotonin reuptake inhibitors (SSRIs) requires further investigation.Methods:This single-center, randomized clinical trial enrolled 213 inpatients with depression and comorbid symptoms. Participants were randomly assigned to receive either SSRIs treatment or antidepressant treatment combined with acupuncture for two weeks. Clinical outcomes were assessed using the Hamilton Depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), Mini-Mental State Examination (MMSE), Pittsburgh Sleep Quality Index (PSQI), and Beck Scale for Suicide Ideation (BSI). The primary outcome was the change in the HAMD reduction rate.Results:Both groups demonstrated significant clinical improvement after two weeks of treatment. However, analysis of covariance (ANCOVA) revealed that the acupuncture group achieved significantly greater reductions in HAMD, HAMA, and PSQI scores, as well as significantly higher MMSE scores, compared with the control group (all adjusted p < 0.05). Hierarchical regression analyses indicated that baseline symptom severity and duration of illness were significant predictors of treatment response.Conclusions:When used as an adjunct to antidepressant therapy, acupuncture provides rapid and broad therapeutic benefits for patients with depression. Compared with SSRI monotherapy, the combined treatment was associated with greater improvements in depressive and anxiety symptoms, sleep quality, and cognitive performance. These findings support the integration of acupuncture into multimodal treatment strategies for managing the complex symptom profile of major depressive disorder.Clinical Trial Registration:The study has been registered on https://itmctr.ccebtcm.org.cn/en/index.html (registration number: ITMCTR2025001802; registration link: https://trialsearch.who.int/Trial2.aspx?TrialID=ITMCTR2025001802).
Funding Information
  • Clinical Collaboration Project on Integrated Traditional Chinese and Western Medicine for Major and Difficult Diseases (ZDYN-2024-A-121)
  • Construction Project of the “Flagship” Department of Chinese and Western Medicine Coordination (Hanw/2024-221)
  • National Key Research and Development Program of China (2025YFC3410000)
  • National Key Research and Development Program of China (2025YFC3410005)
  • National Natural Science Foundation of China (82301688)
  • Natural Science Foundation of Guangdong Province (2025A1515010507)
  • Natural Science Foundation of Guangdong Province (2023A1515011383)
  • Key-Area Research and Development Program of Guangdong Province (2023B0303020001)
  • Science and Technology Program of Guangzhou (2025A03J3357)
  • Research Capacity Improvement Project of Guangzhou Medical University (2024SRP200)
  • Guangzhou Key Clinical Specialty (20252A011017)
  • Guangdong Provincial Clinical Key Specialty of Traditional Chinese Medicine (Acupuncture & Moxibustion) for the 14th Five-Year Plan Period (20252A011017)
  • “1+N” System Construction Project (High-Quality Development) of Guangzhou Acupuncture Hospital (20252A011017)
  • Guangzhou Clinical Core Technology Project of Traditional Chinese Medicine (20252A011017)
  • Guangzhou Science and Technology Project for Traditional Chinese Medicine and Integrated Chinese-Western Medicine (20252A011017)
  • Guangzhou Major, Difficult and Rare Diseases Diagnosis and Treatment Center (Traditional Chinese Medicine Category) Construction Project (Document No. Sui Wei Han [2025] 733)
  • Medical Science and Technology Research Fund Project of Guangdong Province (B2024024)

This publication has 52 references indexed in Scilit: